Genome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration

Neurobiology of Disease

Volumn 63, Issue , 2014, Pages 107-114

  Koldamova, Radosveta ^a   Schug, Jonathan ^b   Lefterova, Martina ^c   Cronican, Andrea A ^a   Fitz, Nicholas F ^a   Davenport, Faith A ^a   Carter, Alexis ^a   Castranio, Emilie L ^a   Lefterov, Iliya ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Animal model; Brain; ChIP seq; Egr1; Histone modifications

Indexed keywords

CALCIUM ION; CELL PROTEIN; CLATHRIN; EARLY GROWTH RESPONSE FACTOR 1; PROTEIN ARC; PROTEIN PICALM; PROTEIN STX6; PROTEIN SYN2; SYNAPTOBREVIN 2; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APP GENE; ARC GENE; ARTICLE; BRAIN LEVEL; CALCIUM TRANSPORT; CELL TRANSPORT; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SEQUENCE; ENDOCYTOSIS; GENE EXPRESSION; GENE FUNCTION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ASSOCIATION; GRIN1 GENE; HIGH THROUGHPUT SEQUENCING; MEMBRANE FUSION; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PICALM GENE; PRIORITY JOURNAL; PROTEIN BINDING; PSEN2 GENE; SIGNAL TRANSDUCTION; SPATIAL MEMORY TEST; STX6 GENE; SYN2 GENE; SYNAPSE VESICLE; UPREGULATION; VAMP2 GENE; WILD TYPE;

ALZHEIMER'S DISEASE; ANIMAL MODEL; BRAIN; CHIP-SEQ; EGR1; HISTONE MODIFICATIONS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CERCOPITHECUS AETHIOPS; CHROMATIN IMMUNOPRECIPITATION; COS CELLS; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 1; ENDOCYTOSIS; GENE REGULATORY NETWORKS; GENOME; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE DEGENERATION; NERVE TISSUE PROTEINS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84890891446     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.11.005     Document Type: Article

References (70)

1. Barski A., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
2. Beckmann A.M., Wilce P.A. Egr transcription factors in the nervous system. Neurochem. Int. 1997, 31:477-510. (discussion 517-6-477).
3. Begemann M., et al. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch. Gen. Psychiatry 2010, 67:879-888.
4. Bhattacharyya S., et al. Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J. Pathol. 2013, 229:286-297.
5. Bossers K., et al. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain 2010, 133:3699-3723.
6. Bozon B., et al. Regulated transcription of the immediate-early gene Zif268: mechanisms and gene dosage-dependent function in synaptic plasticity and memory formation. Hippocampus 2002, 12:570-577.
7. Christy B., Nathans D. DNA binding site of the growth factor-inducible protein Zif268. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:8737-8741.
8. Cronican A.A., et al. Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist. Biochem. Pharmacol. 2010, 79:1310-1316.
9. Cronican A.A., et al. Genome-wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic. PLoS One 2013, 8:e53478-e.
10. Danysz W., Parsons C.G. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int. J. Geriatr. Psychiatry. 2003, 18:S23-S32.
11. Davis S., et al. How necessary is the activation of the immediate early gene zif268 in synaptic plasticity and learningα. Behav. Brain Res. 2003, 142:17-30.
12. Davis S., et al. The formation and stability of recognition memory: what happens upon recallα. Front. Behav. Neurosci. 2010, 4:177-177.
13. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res. Brain Res. Rev. 2001, 36:60-90.
14. Dickey C.A., et al. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein+presenilin-1 transgenic mice. J. Neurosci. 2003, 23:5219-5226.
15. Dickey C.A., et al. Induction of memory-associated immediate early genes by nerve growth factor in rat primary cortical neurons and differentiated mouse Neuro2A cells. Neurosci. Lett. 2004, 366:10-14.
16. Farnham P.J. Insights from genomic profiling of transcription factors. Nat. Rev. Genet. 2009, 10:605-616.
17. Fitz N.F., et al. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J. Neurosci. 2010, 30:6862-6872.
18. Fitz N.F., et al. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J. Neurosci. 2012, 32:13125-13136.
19. Fitz N.F., et al. Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models". Science 2013, 340:924-92c.
20. Fordyce D.E., et al. Genetic and activity-dependent regulation of zif268 expression: association with spatial learning. Hippocampus 1994, 4:559-568.
21. Gniazdowski M., Czyz M. Transcription factors as targets of anticancer drugs. Acta Biochim. Pol. 1999, 46:255-262.
22. Gräff J., Mansuy I.M. Epigenetic codes in cognition and behaviour. Behav. Brain Res. 2008, 192:70-87.
23. Guzowski J.F., et al. Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J. Neurosci. 2001, 21:5089-5098.
24. Harel A., et al. Evidence for CALM in directing VAMP2 trafficking. Traffic 2008, 9:417-429.
25. Harold D., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
26. Heintzman N.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
27. Heintzman N.D., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
28. Honer W.G., et al. Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl. Psychiatry 2012, 2:e114-e.
29. Huang D.W., et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
30. Huang D.W., et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
31. Javitt D.C. Glutamate as a therapeutic target in psychiatric disorders. Mol. Psychiatry 2004, 9:984-97. (979-97, 979.).
32. Javitt D.C., et al. Has an angel shown the wayα Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr. Bull. 2012, 38:958-966.
33. Jones M.W., et al. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat. Neurosci. 2001, 4:289-296.
34. Knapska E., Kaczmarek L. A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENKα. Prog. Neurobiol. 2004, 74:183-211.
35. Kubik S., et al. Using immediate-early genes to map hippocampal subregional functions. Learn. Mem. 2007, 14:758-770.
36. Kubosaki A., et al. Genome-wide investigation of in vivo EGR-1 binding sites in monocytic differentiation. Genome Biol. 2009, 10:R41-R.
37. Lazarov O., et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713.
38. Lee B.M., Mahadevan L.C. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking. J. Cell. Biochem. 2009, 108:22-34.
39. Lefterov I., et al. Expression profiling in APP23 mouse brain: inhibition of Abeta amyloidosis and inflammation in response to LXR agonist treatment. Mol. Neurodegener. 2007, 2:20-20.
40. Lefterov I., et al. Memory deficits in APP23/Abca1+/- mice correlate with the level of Abeta oligomers. ASN Neurol. 2009, 1.
41. Lefterova M.I., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22:2941-2952.
42. Lefterova M.I., et al. Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages. Mol. Cell. Biol. 2010, 30:2078-2089.
43. Mayer S.I., et al. Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors. J. Cell Sci. 2009, 122:3340-3350.
44. McMahon H.T., Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011, 12:517-533.
45. Miller S.E., et al. The molecular basis for the endocytosis of small R-SNAREs by the clathrin adaptor CALM. Cell 2011, 147:1118-1131.
46. Miyashita T., et al. Networks of neurons, networks of genes: an integrated view of memory consolidation. Neurobiol. Learn. Mem. 2008, 89:269-284.
47. Miyashita T., et al. Rapid activation of plasticity-associated gene transcription in hippocampal neurons provides a mechanism for encoding of one-trial experience. J. Neurosci. 2009, 29:898-906.
48. Naert G., Rivest S. Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)/PS1 mice. Front. Cell. Neurosci. 2012, 6:51-51.
49. Ounallah-Saad H., et al. Transcriptional regulation of the murine Presenilin-2 gene reveals similarities and differences to its human orthologue. Gene 2009, 446:81-89.
50. Owen G.R., Brenner E.A. Mapping molecular memory: navigating the cellular pathways of learning. Cell. Mol. Neurobiol. 2012, 32:919-941.
51. Parsons C.G., et al. Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease. Neurotox. Res. 2013, 24:358-369.
52. Pasumarthi K.B., et al. Cloning of the rat fibroblast growth factor-2 promoter region and its response to mitogenic stimuli in glioma C6 cells. J. Neurochem. 1997, 68:898-908.
53. Poirier R., et al. Distinct functions of egr gene family members in cognitive processes. Front. Neurosci. 2008, 2:47-55.
54. Porte Y., et al. Spatial memory in the Morris water maze and activation of cyclic AMP response element-binding (CREB) protein within the mouse hippocampus. Learn. Mem. 2008, 15:885-894.
55. Rebar E.J. Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease. Expert Opin. Investig. Drugs. 2004, 13:829-839.
56. Renbaum P., et al. Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells. Gene 2003, 318:113-124.
57. Ritchie M.F., et al. Transcriptional mechanisms regulating Ca(2+) homeostasis. Cell Calcium 2011, 49:314-321.
58. Sawada K., et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch. Gen. Psychiatry 2005, 62:263-272.
59. Schubert K.O., et al. Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorderα. Mol. Psychiatry 2012, 17:669-681.
60. Silverman E.S., Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 1999, 154:665-670.
61. Sleegers K., et al. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet. 2010, 26:84-93.
62. Stefano L., et al. Up-regulation of tyrosine hydroxylase gene transcription by tetradecanoylphorbol acetate is mediated by the transcription factors Ets-like protein-1 (Elk-1) and Eg-1
63. Steger D.J., et al. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 2010, 24:1035-1044.
64. Sturchler-Pierrat C., et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13287-13292.
65. Tang C., et al. Global analysis of in vivo EGR1-binding sites in erythroleukemia cell using chromatin immunoprecipitation and massively parallel sequencing. Electrophoresis 2010, 31:2936-2943.
66. Thiel G., Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 2002, 193:287-292.
67. Thiel G., et al. Egr-1-A Ca(2+)-regulated transcription factor. Cell Calcium 2010, 47:397-403.
68. Trojer P., Reinberg D. Facultative heterochromatin: is there a distinctive molecular signatureα. Mol. Cell 2007, 28:1-13.
69. Tur G., et al. Factor binding and chromatin modification in the promoter of murine Egr1 gene upon induction. Cell. Mol. Life Sci. 2010, 67:4065-4077.
70. Tuteja G., et al. Extracting transcription factor targets from ChIP-Seq data. Nucleic Acids Res. 2009, 37:e113-e.